APA (7th ed.) Citation

Ramlau, R., & Thomas, M. (2015). Phase I study of lapatinib and pemetrexed in the second-line treatment of advanced or metastatic non-small-cell lung cancer with assessment of circulating cell free thymidylate synthase RNA as a potential biomarker. Clinical lung cancer, 16(5), . https://doi.org/10.1016/j.cllc.2015.01.004

Chicago Style (17th ed.) Citation

Ramlau, Rodryg, and Michael Thomas. "Phase I Study of Lapatinib and Pemetrexed in the Second-line Treatment of Advanced or Metastatic Non-small-cell Lung Cancer with Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker." Clinical Lung Cancer 16, no. 5 (2015). https://doi.org/10.1016/j.cllc.2015.01.004.

MLA (9th ed.) Citation

Ramlau, Rodryg, and Michael Thomas. "Phase I Study of Lapatinib and Pemetrexed in the Second-line Treatment of Advanced or Metastatic Non-small-cell Lung Cancer with Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker." Clinical Lung Cancer, vol. 16, no. 5, 2015, https://doi.org/10.1016/j.cllc.2015.01.004.